Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.
about
At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancerRisk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesisChemoprevention in patients with genetic risk of colorectal cancersClinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancerPerspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practiceIncreased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.DFMO: targeted risk reduction therapy for colorectal neoplasia.Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.Dietary polyamine intake and risk of colorectal adenomatous polypsRole of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas.Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis.Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.Aspirin and colorectal cancer: the promise of precision chemoprevention.Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.Polyamines and Cancer.
P2860
Q27023485-E7BFE7F9-B67D-4504-AB73-0619BB80383CQ28252395-290BE139-54B5-4160-B8E9-8A79C21E6D6FQ34170508-B84249B2-2CDB-4BBC-B980-666F0A46DC3CQ34296467-1CA4CEF2-F9FD-4B9A-910F-123CD3CACB14Q35064951-065B621F-A919-422B-ACF7-097E6B1CD08CQ35133419-A673F44C-53B5-4A1A-89D8-16519EA80F07Q35583635-029A95F7-85A8-4521-9C29-FD3C05F749CAQ35597150-6E574C9C-C737-44DF-9E7A-9BE4CDE6DD8BQ35619102-77DA21F6-7520-4AD6-A4EC-8070949757BCQ36030441-7F2458A4-8FA9-4075-AD80-BBE87D2842E5Q36236838-F5711F3D-1569-4EF7-B8D9-4789D34A7369Q36450416-3064C6A3-CCE7-46EC-ACDF-5E54B6E02988Q36671933-E1131AD4-98A1-4E61-96AB-9C1B7537FF8AQ37567536-B44CDF84-8DFE-4D7D-BFB7-8D2AAFF28920Q38114862-64FAFF5E-2E09-422D-96A8-3E984353109AQ38730064-A52A3E6B-5EF0-40FB-9FE0-DE357C99EAF5Q50084342-45919C0D-3861-4E9E-82FF-3F13F8F639FEQ50100821-C3F4F922-E39D-4761-9083-2237179A878C
P2860
Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@ast
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@en
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@nl
type
label
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@ast
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@en
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@nl
prefLabel
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@ast
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@en
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@nl
P2093
P2860
P356
P1476
Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.
@en
P2093
Christine E McLaren
Eugene W Gerner
Frank L Meyskens
Jason A Zell
Patricia A Thompson
Wen-Pin Chen
P2860
P304
P356
10.1093/JNCI/DJQ325
P407
P577
2010-08-26T00:00:00Z